Epidermal Growth Factor Receptors in Human Breast Carcinoma Cells: A Potential Selective Target for Transforming Growth Factor α-Pseudomonas Exotoxin 40 Fusion Protein

Cancer Research

Volumn 54, Issue 17, 1994, Pages 4703-4709

  Arteaga, Carlos L ^a,c   Hurd, Stephen D ^a   Dugger, Teresa C ^a   Winnier, Angela R ^a   Robertson, J Bruce ^b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTRADIOL; ESTROGEN RECEPTOR; HYBRID PROTEIN; IODINE 125; PSEUDOMONAS EXOTOXIN; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER INHIBITION; CARCINOMA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RECEPTOR BINDING; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; DRUG SCREENING ASSAYS, ANTITUMOR; EPIDERMAL GROWTH FACTOR; EXOTOXINS; FEMALE; HUMANS; MICE; MICE, NUDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0027935422     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Downward, J. Yarden, Y. Mayes, E. Serace, G. Toty, N. Stockwell, P. Ullrich, A. Schlessinger, J. and Waterfield, M. D., Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature (Lond.), 307: 521-527, 1984.
2. Aaronson, S. A., Growth factors and cancer. Science (Washington DC), 254: 1146-1153, 1991.
3. Hayman, M. J., and Enrietto, P. J., Cell transformation by the epidermal growth factor receptor and v-erbB. Cancer Cells, 3: 302-307, 1991.
4. Di Fiore, P. P., Pierce, J. H., Fleming, T. P., Hazan, R. Ullrich, A. King, C. R., Schlessinger, J. and Aaronson, S. A., Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH3T3 cells. Cell, 57: 1063-1070, 1987.
5. Klijn, J.G.M. Berns, P.M.J.J. Schmitz, P.I.M. and Foekens, J. A., The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocrinol. Rev. 13: 3-17, 1992.
6. Sainsbury, J.R.C. Farndon, J. R., Needham, G. K., Malcolm, A. J., and Harris, A. L., Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet, 7: 1398-1402, 1987.
7. Nicholson, S. Richard, J. Sainsbury, C. Halcrow, P. Kelly, P. Angus, B. Wright, C. Henry, J. Farndon, J. R., and Harris, A. L., Epidermal growth factor receptor (EGFr): results of a 6-year follow-up study in operable breast cancer with emphasis on the node negative subgroup. Br. J. Cancer, 63: 146-150, 1991.
8. Guerin, M. Gabillot, M. Mathieu, M.C., Travagli, J. P., Spielmann, M. Andrieu, N. and Riou, G. Structure and expression of c-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance. Int. J. Cancer, 43: 201-208, 1989.
9. Nicholson, S. Sainsbury, J.R.C. Halcrow, P. Chambers, P. Farndon, J. R., and Harris, A. L., Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer. Lancet, 7: 182-185, 1989.
10. Fitzpatrick, S. L., Brightwell, J. Wittliff, J. L., Barrows, G. H., and Schultz, G. S., Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Cancer Res. 44: 3448-3453, 1984.
11. Spitzer, E. Grosse, R. Kunde, D. and Schmidt, E. Growth of mammary epithelial cells in breast cancer biopsies correlates with EGF binding. Int. J. Cancer, 39: 279-282, 1987.
12. Battaglia, F. Scambia, G. Rossi, S. Panici, P. B., Bellantrone, R. Polizzi, G. Querzoli, P. Negrini, R. Iacobelli, S. Crucitti, F. and Mancuso, F. Epidermal growth factor receptor in human breast cancer correlation with steriod hormone receptors and axillary lymph node involvement. Eur. J. Cancer Clin. Oncol. 24: 1685-1690, 1988.
13. Harris, A. L., The epidermal growth factor receptor as a target for therapy. Cancer Cells, 2: 321-323, 1990.
14. Mendelsohn, J. Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies. J. Natl. Cancer Inst. Monogr. 13: 125-131, 1992.
15. Pastan, I. and FitzGerald, D. Recombinant toxins for cancer treatment. Science (Washington DC), 254: 1173-1177, 1991.
16. Chaudhary, V. K., FitzGerald, D. J., Adhya, S. and Pastan, I. Activity of a recombinant fusion protein between transforming growth factor type α and Pseudomonas exotoxin. Proc. Natl. Acad. Sci. USA, 84: 4538-4542, 1987.
17. DeFeo-Jones, D. Tai, J. Y., Wegrzyn, R. J., Vuocolo, G. A., Baker, A. E., Payne, L. S., Garsky, V. M., Oliff, A. and Riemen, M. W., Structure-function analysis of synthetic and recombinant derivatives of transforming growth factor a. Mol. Cell. Biol. 8: 2999-3007, 1988.
18. Edwards, G. M., DeFeo-Jones, D. Tai, J. Y., Vuocolo, G. A., Patrick, D. R., Heimbrook, D. C., and Oliff, A. Epidermal growth factor receptor binding is affected by structural determinants in the toxin domain of transforming growth factor α-Pseudomonas exotoxin fusion proteins. Mol. Cell. Biol. 9: 2860-2867, 1989.
19. Ogata, M. Chaudhary, V. K., Pastan, I. and FitzGerald, D. J., Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37, 000-Da toxin fragment that is translocated to the cytosol. J. Biol. Chem. 265: 20678-20685, 1990.
20. Heimbrook, D. C., Stirdivant, S. M., Ahern, J. D., Balishin, N. L., Patrick, D. R., Edwards, G. M., DeFeo-Jones, D. Fitzgerald, D. J., Pastan, I. and Oliff, A. Transforming growth factor α-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts. Proc. Natl. Acad. Sci. USA, 87: 4697-4701, 1990.
21. Siegall, C. B., Xu, Y. H., Chaudhary, V. K., Adhya, S. FitzGerald, D. and Pastan, I. Cytotoxic activities of a fusion protein comprised of TGFa and Pseudomonas exotoxin. FASEB J. 3: 2647-2652, 1989.
22. Pai, L. H., Gallo, M. G., FitzGerald, D. J., and Pastan, I. Antitumor activity of a transforming growth factor α-Pseudomonas exotoxin fusion protein (TGF-a-PE40). Cancer Res. 57: 2808-2812, 1991.
23. Zajchowski, D. Band, V. Pauzie, N. Tager, A. Stampfer, M. and Sager, R. Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells. Cancer Res. 48: 7041-7047, 1988.
24. Limbird, L. E., Identification of receptors using direct radioligand binding techniques. In: L. E. Limbird (ed.), Cell Surface Receptors: A Short Course on Theory and Methods, pp. 51-96. Boston: Martinus Nijhoff Publishing, 1986.
25. Stoscheck, C. M., and Carpenter, G. Characteristics of antibodies to the epidermal growth factor receptor-kinase. Arch. Biochem. Biophys. 227: 457-467, 1983.
26. Shaw, J. P., Akiyoshi, D. E., Arrigo, D. A., Rhoad, A. E., Sullivan, B. Thomas, J. Genbauffe, F. S., Bacha, P. and Nichols, J. C., Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins. J. Biol. Chem. 266: 21118-21124, 1991.
27. Wels, W. Harwerth, I. M., Mueller, M. Groner, B. and Hynes, N. Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor. Cancer Res. 52: 6310-6317, 1992.
28. Huang, S. S., Koh, H. A., Konish, Y. Bullock, R. D., and Huang, J. S., Differential processing and turnover of the oncogenically activated neu-erbB2 gene product and its normal cellular counterpart. J. Biol. Chem. 265: 3340-3346, 1990.
29. Gladhaug, I. P., and Christoffersen, T. Rapid constitutive internalization and externalization of epidermal growth factor receptors in isolated rat hepatocytes. J. Biol. Chem. 263: 12199-12203, 1988.
30. Phillips, P. C., Levow, C. Catterall, M. Colvin, O. M., Pastan, I. and Brem, H. Transforming growth factor a-Pseudomonas exotoxin fusion protein (TGF-α-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice. Cancer Res. 54: 1008-1015, 1994.
31. Hynes, N. E., Marte, B. M., Hellmann, P. Beerli, R. Groner, N. and Wels, W. Recombinant single chain immunotoxins specific for EGF and erbB-2 receptors inhibit in vivo and in vitro tumor cell growth. J. Cell. Biochem. Suppl. 18D: 237, 1994.
32. Akiyama, S. I., Gottesman, M. M., Hanover, J. A., FitzGerald, D.J.P. Willingham, M. C., and Pastan, I. Verapamil enhances the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin and antitransferrin receptor with Pseudomonas exotoxin. J. Cell. Physiol. 720: 271-279, 1984.
33. Filmus, J. Trent, J. M., Pollak, M. N., and Buick, R. N., Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants. Mol. Cell. Biol. 7: 2571-2577, 1987.
34. Santon, J. B., Cronin, M. T., MacLeod, C. L., Mendelsohn, J. Masui, H. and Gill, G. N., Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice. Cancer Res. 46: 4701-4705, 1986.